Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is 180 Life Sciences Corp. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
The company has declared Negative results for the last 4 consecutive quarters
- INTEREST(HY) At USD 3.74 MM has Grown at 42,952.44%
- PRE-TAX PROFIT(Q) At USD -11.59 MM has Fallen at -389.23%
- NET PROFIT(Q) At USD -11.59 MM has Fallen at -389.23%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -42.62%, its profits have risen by 71%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -42.62% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is 180 Life Sciences Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
180 Life Sciences Corp.
-42.62%
0.25
928.37%
S&P 500
25.41%
1.92
13.25%
Quality key factors
Factor
Value
Sales Growth (5y)
-1.00%
EBIT Growth (5y)
-329.35%
EBIT to Interest (avg)
-6.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.01
Tax Ratio
4.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
45.48%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.12
EV to EBIT
-0.18
EV to EBITDA
-0.18
EV to Capital Employed
0.09
EV to Sales
9.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-52.20%
ROE (Latest)
-50.58%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
10What is working for the Company
NET SALES(HY)
Higher at USD 5.3 MM
NET PROFIT(HY)
Higher at USD -25.44 MM
RAW MATERIAL COST(Y)
Fallen by -8,346% (YoY
-26What is not working for the Company
INTEREST(HY)
At USD 3.74 MM has Grown at 42,952.44%
PRE-TAX PROFIT(Q)
At USD -11.59 MM has Fallen at -389.23%
NET PROFIT(Q)
At USD -11.59 MM has Fallen at -389.23%
OPERATING CASH FLOW(Y)
Lowest at USD -45.64 MM
ROCE(HY)
Lowest at -590.15%
Here's what is working for 180 Life Sciences Corp.
Net Sales
Higher at USD 5.3 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Raw Material Cost
Fallen by -8,346% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for 180 Life Sciences Corp.
Interest
At USD 3.74 MM has Grown at 42,952.44%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Pre-Tax Profit
At USD -11.59 MM has Fallen at -389.23%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -11.59 MM has Fallen at -389.23%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -45.64 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)






